Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
about
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studiesEffects of NSAIDs on the risk factors of colorectal cancer: a mini reviewPUFAs: Structures, Metabolism and FunctionsNSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesMolecular cancer prevention: Current status and future directionsImpairment of aspirin antiplatelet effects by non-opioid analgesic medicationCardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implicationsMitigating the cardiovascular and renal effects of NSAIDs50th anniversary of the discovery of ibuprofen: an interview with Dr Stewart AdamsCause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide studyPostoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective dataSafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksThe impact of NSAID treatment on cardiovascular risk - insight from Danish observational data.Clinical trial data in support of changing guidelines in osteoarthritis treatment.Opioid use for Chronic Pain Management in Italy: Results from the Orthopedic Instant Pain Survey Project.Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiativeNon-steroidal anti-inflammatory drugs for the treatment of pain and immobility-associated osteoarthritis: consensus guidance for primary care.Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjectsSafety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.The PanAM study: a multi-center, double-blinded, randomized, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal traumaAnalgesic use in a Norwegian general population: change over time and high-risk use--The Tromsø Study.Prevalence, trends, patterns and associations of analgesic use in GermanyGene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older.Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain.Ibuprofen - a Safe Analgesic During Cardiac Surgery Recovery? A Randomized Controlled Trial.Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates.Prevalence and Characteristics of Central Compared to Obstructive Sleep Apnea: Analyses from the Sleep Heart Health Study Cohort.Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Further Effort is Needed to Improve Management of Chronic Pain in Primary Care. Results from the Arkys ProjectEffectiveness of the CardioPain initiative in reducing inappropriate NSAID prescriptions in pain therapy among high cardiovascular risk patients: an informative Italian surveyInflammation in Depression and the Potential for Anti-Inflammatory TreatmentMultimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial.The NSAID dilemma: managing osteoarthritis in high-risk patients.5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity.Room for improvement: unmet needs in postoperative pain management.Ibuprofen: from invention to an OTC therapeutic mainstay.
P2860
Q21144617-7039A80A-AB06-486B-984A-CF3570AC64C2Q26746884-29BC66AC-FF6A-46F6-826A-D458A4211AFEQ26771687-38756D26-62AF-414F-98FD-1DCDCDF5166CQ26784322-F2B6C95F-8C2F-4FF3-8490-0109AA3A67D2Q26797207-9A52C937-2885-4971-A16F-C37162D385CDQ26801633-6FD4AB40-AFFD-4E66-AB6A-87D686ABE846Q27002539-7F9B0739-5FA7-4190-9EC9-4F570587456DQ27022837-22C664D5-0050-42E2-ABAD-DCC455929EABQ28253389-8C7E91D4-C9B8-4218-BD2C-A6A6A94C03A0Q28485380-24B7266F-386C-42FF-93EE-6323AB5340BFQ30570853-904B832A-890E-453A-9246-2221E5174F5EQ30629677-5292D4FE-FEB7-40FE-AF5E-8A6F02D894B5Q30791071-8B204954-BCD5-43EE-8CE5-E69DEE7116B9Q30804806-BCFFEAA0-4384-4FE1-9D4A-CE4F3EC8000EQ33851224-1802A4EA-9E5E-47A5-A304-F88A8E399275Q34117657-FC84A3AC-7505-4934-9F9B-B4EFC9F22D48Q34203458-A666317F-9268-4D90-AEEF-7616526610E6Q34322559-C373FA4F-CE12-47B3-BC24-1CB9971DFD29Q34474876-E05FF979-0737-4EC8-BB78-130CBC70CA52Q34474985-9FB88369-C44B-49BE-8917-ECC3000D8BAAQ34477672-FDFC7191-DC55-4529-979A-DA0547095224Q35654986-81F83E6B-FE71-435A-81DF-5E3E9D4A2833Q35795918-9033904B-F598-4A01-B88E-6825F68681A8Q36017548-7FE94CE4-45E1-4B37-B812-70DE91179C18Q36023793-0A0FDF1D-1E15-403E-8FDD-45A6026D3DC2Q36086215-8219DA1E-DBED-492F-A394-899C4241F7EBQ36174087-0F1D2E43-EFED-4F64-BB47-06212D9869B2Q36235082-6799E456-931D-48BB-B02F-2DF3195810F1Q36388056-9C8F1B04-CB33-4C4C-AFA5-6E3C56325ECAQ36661519-01770315-B7F0-453D-AAC0-D2469EEE7368Q37009101-6F1BAEE0-6849-42BA-AE38-FAEAA055D14CQ37058791-F140AB3C-D06F-4A6A-8799-ABAB8AACD4A1Q37090319-9BD48AB1-3F5F-4741-ADEB-C3A930B519E1Q37097576-AC9B7E5E-6168-4FD1-80F6-A34F34E9965DQ37310528-82DDB30F-D173-488C-B39A-DF0480E786AFQ37684188-21E639CE-BA9D-4A37-A0A9-0CE04521173EQ37949849-00F22C12-29FE-4031-BB66-B1D8DB2E81B6Q37986694-A6B836E7-2D53-4E3E-A5FC-2D5DECB3E52BQ38006982-4D666973-96EE-406C-B8D7-9915A9D99207Q38060825-0882377C-CE2B-4BB9-AB93-5D34C29B44DD
P2860
Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Duration of treatment with non ...... on: a nationwide cohort study.
@ast
Duration of treatment with non ...... on: a nationwide cohort study.
@en
Duration of treatment with non ...... on: a nationwide cohort study.
@nl
type
label
Duration of treatment with non ...... on: a nationwide cohort study.
@ast
Duration of treatment with non ...... on: a nationwide cohort study.
@en
Duration of treatment with non ...... on: a nationwide cohort study.
@nl
prefLabel
Duration of treatment with non ...... on: a nationwide cohort study.
@ast
Duration of treatment with non ...... on: a nationwide cohort study.
@en
Duration of treatment with non ...... on: a nationwide cohort study.
@nl
P2093
P50
P1433
P1476
Duration of treatment with non ...... on: a nationwide cohort study.
@en
P2093
Anne-Marie Schjerning Olsen
Emil L Fosbøl
Jesper Lindhardsen
Mette Charlot
Morten Lamberts
P304
P356
10.1161/CIRCULATIONAHA.110.004671
P407
P50
P577
2011-05-09T00:00:00Z